Track Flow Signal on Ultrasound Power Doppler Along the Needle Tract Following Percutaneous Liver Biopsy

2021 ◽  
Author(s):  
Umberto G. Rossi ◽  
Maurizio Cariati
Keyword(s):  
Liver Biopsy ◽  
Power Doppler ◽  
Percutaneous Liver Biopsy ◽  
Flow Signal ◽  
Needle Tract ◽  
Ultrasound Power

Complications and seeding risk after percutaneous liver biopsy in an oncological setting.

2018 ◽  
Vol 36 (4_suppl) ◽  
pp. 246-246 ◽  
Author(s):  
Katja De Paepe ◽  
Lawrence Bonne ◽  
Nicos Fotiadis ◽  
Naureen Starling ◽  
Ian Chau ◽  
...  
Keyword(s):  
Liver Biopsy ◽  
Percutaneous Biopsy ◽  
Minimal Risk ◽  
Percutaneous Liver Biopsy ◽  
Ct Guided ◽  
Non Invasive ◽  
Needle Tract ◽  
Invasive Method ◽  
Tumor Types

246 Background: Percutaneous biopsy of suspected liver metastases is a common practice for diagnostic purposes. Particularly, in the setting of oncological clinical trials, it is a relatively non-invasive method to obtain sufficient tissue for molecular analyses at regular set time points. However, various complications may occur, including seeding of the tumour along the biopsy tract. Only few reports exist on the actual incidence of seeding, on a limited number of tumor types. The aim of this study was to evaluate the technique’s safety and risk of seeding. Methods: All patients with an ultrasound or CT-guided liver biopsy between 2012-2016 were included. Medical records were reviewed retrospectively for post-biopsy complications and all follow-up imaging was re-assessed for the presence of seeding, defined as tumoral deposits in the biopsy needle tract. Results: In total 782 biopsies were performed in 550 patients (282 women, 268 men; mean age of 61 years), 43.9% (343/782) for trials and 56.1% (439/782) for diagnostic/molecular purposes, 93.7% (733/782) were diagnostic, revealing malignancy in 96.9% (710/733). Number of biopsies per patient ranged between 1 (n=387) to 7 (n=1), a co-axial system was used in 70.6% (552/782) and multiple passes in 29.4% (230/782). Complications were reported in 8.8% (69/782), more often pain (4.7%) and hypotension/vasovagal (2.3%). Admission and/or re-intervention were needed for more severe complications as bleeding (1.0%), sepsis/fever (1.1%), pulmonary embolism (0.3%) and pneumothorax (0.4%). Seeding was seen in 1.1% (8/782) of cases (2/44 melanoma, 1/11 GIST, 1/39 cholangiocarcinoma, 1/247 colorectal, 1/14 oesophagus, 1/97 breast, 1/31 prostate). Mean time for seeding was 208 days (range 43-469 d); mean post-biopsy survival time was 495 days in the seeding and 349 days in the non-seeding group. Conclusions: Percutaneous liver biopsy is a highly effective and safe method for tissue collection, with only a minimal risk of seeding.

A Case of Hemobilia Secondary to Percutaneous Liver Biopsy: The Clinical Course of Spontaneous Recovery and Changes of "Color Mosaic Appearance" on Color Doppler Sonogram

Choonpa Igaku ◽  
2006 ◽  
Vol 33 (6) ◽  
pp. 673-679
Author(s):  
Shuichi YAMAMOTO ◽  
Hitoshi MARUYAMA ◽  
Ayaka SEZA ◽  
Yoshio MASUYA ◽  
Toshio TUYUGUCHI ◽  
...  
Keyword(s):  
Liver Biopsy ◽  
Spontaneous Recovery ◽  
Clinical Course ◽  
Color Doppler ◽  
Percutaneous Liver Biopsy

Sonographically Guided Percutaneous Liver Biopsy in Infants: A Retrospective Review

2006 ◽  
Vol 187 (6) ◽  
pp. W644-W649 ◽  
Author(s):  
Joao Guilherme Amaral ◽  
Jordan Schwartz ◽  
Peter Chait ◽  
Michael Temple ◽  
Philip John ◽  
...  
Keyword(s):  
Liver Biopsy ◽  
Retrospective Review ◽  
Percutaneous Liver Biopsy

A 21-year experience with major hemorrhage after percutaneous liver biopsy

1990 ◽  
Vol 99 (5) ◽  
pp. 1396-1400 ◽  
Author(s):  
Douglas B. McGill ◽  
Jorge Rakela ◽  
Alan R. Zinsmeister ◽  
Beverly J. Ott
Keyword(s):  
Liver Biopsy ◽  
Percutaneous Liver Biopsy ◽  
Major Hemorrhage
Sign in / Sign up

Export Citation Format

Share Document